Evaluating 10 Commercially Available SARS-CoV-2 Rapid Serological Tests by Use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) Method

Author:

Dortet Laurent12ORCID,Ronat Jean-Baptiste23,Vauloup-Fellous Christelle45,Langendorf Céline6,Mendels David-Alexis7,Emeraud Cécile12,Oueslati Saoussen2,Girlich Delphine2,Chauvin Anthony8,Afdjei Ali9,Bernabeu Sandrine12,Le Pape Samuel4,Kallala Rim4,Rochard Alice2,Verstuyft Celine10,Fortineau Nicolas12,Roque-Afonso Anne-Marie45,Naas Thierry12ORCID

Affiliation:

1. Bacteriology-Hygiene Unit, Bicêtre Hospital, Associated French National Reference Center for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Assistance Publique/Hôpitaux de Paris, Le Kremlin-Bicêtre, France

2. Team Resist UMR1184 Immunology of Viral, Auto-immune, Hematological, and Bacterial Diseases (IMVA-HB), INSERM, Université Paris-Saclay, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France

3. Médecins Sans Frontières, Mini-Lab Project, Paris, France

4. Service de Virologie, Hôpital Paul-Brousse, Villejuif, France

5. INSERM U1193, Université Paris-Saclay, Villejuif, France

6. Epicentre, Paris, France

7. XRapid Group, Aix en Provence, France

8. Emergency Departement, Hopital Lariboisière, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Paris Diderot, Université de Paris, Paris, France

9. Emergency Department, Hôpital Parly-2, Le Chesnay, France

10. CRB Paris Sud, Hôpital Bicêtre, Le Kremlin-Bicêtre, France

Abstract

Numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapid serological tests have been developed, but their accuracy has usually been assessed using very few samples, and rigorous comparisons between these tests are scarce. In this study, we evaluated and compared 10 commercially available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodology.

Funder

Agence de l'innovation de defense

Assistance Publique - Hôpitaux de Paris

Médecins Sans Frontières

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3